Tag Archives: demanding

Federal prosecutors launch Alnylam marketing probe, demanding Onpattro documents

Busy launching several new drugs, RNA biotech Alnylam posted a big revenue increase in 2020—and it expects more growth in 2021, partly thanks to its top-selling Onpattro drug. But now the U.S. Department of Justice is investigating its marketing practices for that very product.  The U.S. Department of Justice subpoenaed the biotech last week, demanding documents that detail its Onpattro marketing… Read More »